How to tailor an eye examination and what technology to consider.
As consistent use of digital devices remains a fact of life for people of virtually all ages, consider this expert advice
Technology can facilitate secure communication between physician and patient
When preventing disease, optometrists should not give away any care
Rebecca Alexander, LCSW-R, MPH, has been gradually losing both her vision and hearing since she was a teenager due to Usher syndrome type 3. She discusses the importance of making practice accessible for those with vision loss in an exclusive interview.
Kristen Ingenito, MBA, gives key takeaways from her G360 presentation, "A bird’s eye view of innovation."
OrCam devices incorporate cutting-edge AI advancements that empower patients to live more independent lives.
Educate providers, build a referral network, and add tools of the trade
With advanced, easy-to-fit multifocal lens technologies, patients don’t need to compromise
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, shares his number 1 tip for managing dry eye.
As efforts continue across the globe, optometrists need to take action in clinics.
Phillip T. Yuhas, OD, PhD, FAAO, discusses key takeaways from his presentation, "Stress management: the emerging role of ocular biomechanics in glaucoma," which he presented during the 2022 AAOpt.
Nasal spray may fill the gaps left by artificial tears.
At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.
Prepare for the future of contact lenses with innovations on the horizon
Shifting the treatment paradigm can lead to less pain, inflammation
Optometry Times chats with Michael Chaglasian, OD, FAAO during this year's Glaucoma 360 meeting in San Francisco, California.
Bryan Wilson, executive director of medical affairs at Genentech, details why Birmingham, Alabama was chosen as the community to study the effects of diabetic eye disease among African Americans in a new manuscript from the ADA and Genentech.
Early detection of incipient geographic atrophy is critical to identify patients at greatest risk of progression and who may benefit most from newly approved complement inhibition therapies.
Optometrists must identify and mitigate complications for this patient base.
When considering the best modality these lenses' stability are superior.
Doctors should consider a few key points before writing a prescription.
Sherrol Reynolds, OD, gives key takeaways from her co-presentation on the most common autoimmune diseases and their latest updates, which she discussed at AAOpt 2022.
Orbital cellulitis, orbital mass, and potential other conditions could mask diagnosis
For patients with keratoconus-related inflammation, an intracanalicular steroid insert rivals the effectiveness of eye drops while boosting adherence.
Successful outcomes demand both corneal and contact lens expertise.
Michele Andrews, OD, vice president of professional and government affairs for CooperVision, and Terri A. Gossard, OD, MS, member of the AOA board of trustees, sat down with Optometry Times to discuss the goals and tactics of The Myopia Collective.
Nystagmus can be an intimidating condition, but understanding the treatment options can help patients feel as if they have more control.